Skikos, Crawford, Skikos & Joseph LLP has a national reputation for successful litigation against some of the world’s largest pharmaceutical and medical device corporations.
Every year, thousands of people suffer severe adverse reactions to prescription and over-the-counter drugs. Likewise, some medical devices intended to improve lives only create further agony. Those who are affected have an opportunity to hold pharmaceutical and device companies accountable for their harmful actions and negligence.
These cases are often notable for their significant scale and complexity. They involve intense investigation, multiple jurisdictions, and a significant number of parties seeking similar damages. As a result, state and federal courts may occasionally bring cases together to create a global resolution, where all the claims against a defendant are settled at one time. Each claim is then assessed individually and reviewed to ensure that allocations of awards are fair and justified.
Skikos, Crawford, Skikos & Joseph LLP focuses on navigating these complex matters. For example, in the Reglan/Metoclopramide Litigation Judicial Council Coordination Proceedings the firm helped nearly 5,000 plaintiffs recover a $250 million settlement. The litigation included 16 pharmaceutical defendant groups in cases across 18 different venues and three coordinated jurisdictions.
In large multi-claimant cases, the firm frequently plays a dual role. In addition to serving individual clients, the firm’s attorneys serve in court-appointed leadership roles. In the DePuy ASR hip implant multidistrict litigation, firm co-founder Steve Skikos was appointed co-lead counsel by the Honorable David Katz. The case resulted in a multi-billion-dollar settlement for almost 10,000 plaintiffs who suffered as a result of the recalled device. [DePuy Orthopedics Inc. ASR Hip Implant Products Liability Litigation, MDL No. 2197, U.S. District Court, Northern District of Ohio]